NCT03273023Completed
PROMUS PREMIER™ China Post-Approval Study
Post-Approval Study of the PROMUS PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System in China
Source: ClinicalTrials.gov · Last updated 22 Jul 2026
Brief summary (registry, in English)
To compile real-world clinical outcome data for the Promus PREMIERTM Everolimus-Eluting Platinum Chromium Coronary Stent System (Promus PREMIERTM Stent System) in routine clinical practice in China.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 2059 (actual)
- First submitted
- 4 Sept 2017
- Start date
- 11 Jan 2018
- Primary completion date
- 28 Dec 2020
- Lead sponsor
- Boston Scientific Corporation
- Diseases
- Coronary artery disease
- NCT number
- NCT03273023
What you commit to
- Study type: Observational
- Participants enrolled: 2059
- From 11 Jan 2018 to the primary completion date, 28 Dec 2020
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Exclusion criteria are not required in the PE PREMIERTM China Post-Approval Study which is an "all comers" study.
Who the study is looking for
- Subject must be at least 18 years of age
- Subject understands and provides written informed consent
- Subject who is clinically indicated and will have an attempt of at least one Promus PREMIERTM Stent OR Subject who is clinically indicated and was implanted with at least one Promus PREMIERTM Stent
- Subject is willing to comply with all protocol-required follow-up evaluation
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The Second Affiliated Hospital of Harbin Medical University Coordinator of this site? Confirm its status | Harbin | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.